Cipher Pharmaceuticals Inc. (TSX:CPH)
Canada · Delayed Price · Currency is CAD 16.72
-0.17 (-0.98%)
Jun 9, 2026, 3:59 PM EST
Cipher Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 17.36 | 11.55 | 20.38 | 26.64 | 7.76 | 4.39 |
Depreciation & Amortization | 6.94 | 4.02 | 1.23 | 0.99 | 0.7 | 1.21 |
Stock-Based Compensation | 1.59 | 1.07 | 1.19 | 0.4 | 0.14 | 0.12 |
Other Adjustments | -6.92 | -6.04 | -3.53 | -14.27 | 0.54 | 4.26 |
Change in Receivables | 3.09 | -8.77 | 1.71 | -0.14 | 2.56 | -0.34 |
Changes in Inventories | 2.36 | 3.6 | -0.83 | -0.5 | -0.76 | 0.15 |
Changes in Accounts Payable | -1.34 | 1.28 | 0.53 | -1.45 | -1.23 | 0.28 |
Changes in Income Taxes Payable | 0.01 | 0.05 | -4.97 | -0.85 | 3.59 | 1.53 |
Changes in Unearned Revenue | 7.67 | 12.79 | 0.27 | -0.19 | 0.14 | 0.2 |
Changes in Other Operating Activities | -0.75 | 0.01 | 0.01 | 0.1 | 0.37 | -0.1 |
Operating Cash Flow | 29.88 | 19.55 | 16 | 10.73 | 13.81 | 11.69 |
Operating Cash Flow Growth | 128.50% | 22.17% | 49.18% | -22.36% | 18.16% | 31.95% |
Capital Expenditures | -0.01 | -0.04 | -0.02 | -0.08 | - | -0.01 |
Purchases of Intangible Assets | - | - | - | - | - | -0.75 |
Payments for Business Acquisitions | - | -80 | -0.12 | - | - | - |
Investing Cash Flow | 0.04 | -80.04 | -0.14 | -0.08 | - | -0.76 |
Short-Term Debt Repaid | -7.5 | - | - | - | - | - |
Net Short-Term Debt Issued (Repaid) | -7.5 | - | - | - | - | - |
Long-Term Debt Issued | - | 40 | - | - | - | - |
Long-Term Debt Repaid | - | - | - | - | - | -7.67 |
Net Long-Term Debt Issued (Repaid) | - | 40 | - | - | - | -7.67 |
Issuance of Common Stock | 0.1 | 0.15 | 0.43 | 0.13 | 0.08 | 0.04 |
Repurchase of Common Stock | -3.72 | -0.18 | -5.56 | -1.99 | -1.72 | -0.08 |
Net Common Stock Issued (Repurchased) | -3.62 | -0.02 | -5.13 | -1.86 | -1.64 | -0.04 |
Other Financing Activities | -0.34 | -0.68 | -0.11 | -0.06 | -0.83 | -0.43 |
Financing Cash Flow | -30.96 | 39.3 | -5.24 | -1.91 | -2.47 | -8.13 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -0.06 | -0.79 | 0.38 | -0.44 | 0.06 | - |
Net Cash Flow | -1.04 | -21.2 | 10.61 | 8.73 | 11.34 | 2.8 |
Free Cash Flow | 29.87 | 19.5 | 15.98 | 10.64 | 13.81 | 11.68 |
Free Cash Flow Growth | 53.18% | 22.05% | 50.11% | -22.95% | 18.26% | 44.85% |
FCF Margin | 59.68% | 58.45% | 75.50% | 51.48% | 62.95% | 54.06% |
Free Cash Flow Per Share | 1.14 | 0.77 | 0.63 | 0.40 | 0.51 | 0.43 |
Levered Free Cash Flow | 24.74 | 73.24 | 16.6 | 24.65 | 10.58 | -0.02 |
Unlevered Free Cash Flow | 35.99 | 41.75 | 12.34 | 23.66 | 11.1 | 7.78 |